Advertisement

Topics

A new study finds that the U.S. pays up to 4.1 times more for brand-named prescription drugs than in other countries, and that if Medicare Part D had used the same pricing as others, the U.S. could have saved nearly $73 billion last year. https://buff.ly/

21:00 EDT 11 May 2019 | STAT

A new study finds that the U.S. pays up to 4.1 times more for brand-named prescription drugs than in other countries, and that if Medicare Part D had used the same pricing as others, the U.S. could have saved nearly $73 billion last year. https://buff.ly/2JABTX5 

Original Article: A new study finds that the U.S. pays up to 4.1 times more for brand-named prescription drugs than in other countries, and that if Medicare Part D had used the same pricing as others, the U.S. could have saved nearly $73 billion last year. https://buff.ly/

NEXT ARTICLE

More From BioPortfolio on "A new study finds that the U.S. pays up to 4.1 times more for brand-named prescription drugs than in other countries, and that if Medicare Part D had used the same pricing as others, the U.S. could have saved nearly $73 billion last year. https://buff.ly/"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...